Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Immune cells might contribute to hair loss caused by a specific mutation.

A specific mutation in the TRPV3 gene causes hair follicle cells to develop improperly, leading to hair loss.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Olmsted syndrome can be inherited as an autosomal recessive trait due to a rare TRPV3 gene mutation.

A new genetic mutation in the TRPV3 gene causes Olmsted-like syndrome in a Mongolian family.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The TRPV3 channel structure changes linked to severe itch and hyperkeratosis were identified using cryo-EM.

A gene mutation causes early keratinocyte maturation leading to hair loss in Olmsted syndrome.

A specific gene mutation causes Olmsted syndrome.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

A child with Olmsted syndrome showed mild improvement in hair and skin issues with treatment.

TRPV3 gene mutations cause Olmsted syndrome symptoms, but severity varies.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Acid can block TRPV3 from outside the cell but boost its function from inside.

Scientists found key proteins and genes that affect skin and hair health, and identified potential new treatments for hair loss, skin disorders, and wound healing.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

A rare EGFR mutation in newborns leads to severe health issues and early death.

C-scores can help predict gain-of-function and loss-of-function mutations.

TRPV3 in skin cells causes inflammation and cell death.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

Carvacrol activates the TRPV3 channel, which may help design new skin treatments.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

The TRPV3 gene variant may cause the long-haired suri alpaca coat.

Blocking TRPV3 may help treat itch in dry skin conditions.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

Activating TRPV3 stops human hair growth.